Weight Loss

SAN DIEGO — A virtual diabetes-tailored weight management program resulted in beneficial and clinically meaningful effects on glucose levels, body weight and diabetes distress among adults with type 2 diabetes.

SAN DIEGO — Treatment with the melanocortin-4 receptor agonist setmelanotide was associated with significant weight loss among patients with hypothalamic obesity, according to a presenter at ObesityWeek.

SAN DIEGO — Adolescents with obesity had a BMI reduction of 16.1% at 68 weeks with once-weekly subcutaneous semaglutide 2.4 mg plus lifestyle intervention, results similar to those seen with adults, according to top-line results presented at ObesityWeek 2022.

Once-daily liraglutide was not associated with greater weight loss for youths with obesity and Prader-Willi syndrome compared with placebo, according to a study published in The Journal of Clinical Endocrinology & Metabolism.

BOSTON — New drugs and devices can reduce weight and weight-related comorbidities, and physicians should optimize therapy choices for patients with several common conditions to reduce their cardiometabolic risk, according to a speaker.

The AGA has released its first guideline endorsing the use of four medications for obesity management, when paired with lifestyle interventions, for patients who have failed to lose weight with diet and exercise alone.

The American Diabetes Association and the European Association for the Study of Diabetes released an updated consensus statement on the management of hyperglycemia among adults with type 2 diabetes.

GENEVA — Lower BMI may increase risk for lung cancer, according to results of an ongoing prospective study presented at World Cancer Congress.

Two-thirds of patients who underwent Roux-en-Y gastric bypass and sleeve gastrectomy experienced clinically important improvements in pain and physical function 7 years after surgery, according to research published in JAMA Network Open.

While both Roux-en-Y gastric bypass and sleeve gastrectomy resulted in weight loss and lower HbA1c across all racial and ethnic groups, Black and Hispanic patients who underwent gastric bypass experienced more postsurgical complications.